SCHEMBL13680504

SCHEMBL13680504

CNC(=O)c1ccc(-c2ccc(C)o2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 4/20 0.50
HDAC6 Q9UBN7 2/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
MMP13 P45452 2/20 0.47
HPGD P15428 2/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
PKM P14618 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
ALOX12 P18054 1/20 0.47
TSHR P16473 1/20 0.46
PTPN1 P18031 2/20 0.44
PTPN11 Q06124 1/20 0.44
GSK3B P49841 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680452 0.80 GSK3B (0.61) HPGDSMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL13680465 0.80 GSK3B (0.61) HPGDSMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL5655892 0.79 GSK3B (0.64) HPGDHTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL13680707 0.79 MAPT (0.40) HPGDHTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL13680503 0.79 GSK3B (0.62) HPGDSMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL13680510 0.77 ALDH1A1 (0.52) MMP13HPGDSMN1; SMN2MEN1ALDH1A1
SCHEMBL16198923 0.77 HDAC6 (0.70) PLK1HDAC6HDAC2HDAC8MMP13
SCHEMBL14115137 0.77 HDAC6 (0.70) PLK1HDAC6HDAC2HDAC8MMP13
SCHEMBL23197679 0.77 TDP1 (0.56) HPGDSMN1; SMN2MEN1ALDH1A1MAPT
SCHEMBL13680494 0.76 ALDH1A1 (0.46) HPGDSMN1; SMN2MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed